229.02 - 234.51
169.21 - 260.10
55.82M / 54.92M (Avg.)
32.24 | 7.26
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
8.40%
Revenue growth under 50% of VUZI's 52.37%. Michael Burry would suspect a deteriorating sales pipeline or weaker brand.
8.86%
Gross profit growth under 50% of VUZI's 102.03%. Michael Burry would be concerned about a severe competitive disadvantage.
12.86%
Positive EBIT growth while VUZI is negative. John Neff might see a substantial edge in operational management.
12.86%
Positive operating income growth while VUZI is negative. John Neff might view this as a competitive edge in operations.
12.62%
Net income growth at 50-75% of VUZI's 24.57%. Martin Whitman would question fundamental disadvantages in expenses or demand.
13.85%
EPS growth at 50-75% of VUZI's 25.00%. Martin Whitman would suspect a lag in operational efficiency or a higher share count.
12.31%
Diluted EPS growth under 50% of VUZI's 25.00%. Michael Burry would worry about an eroding competitive position or excessive dilution.
-1.12%
Share reduction while VUZI is at 0.16%. Joel Greenblatt would see if the company has a better buyback policy than the competitor.
-0.93%
Reduced diluted shares while VUZI is at 0.16%. Joel Greenblatt would see a relative advantage if the competitor is diluting more.
-2.88%
Dividend reduction while VUZI stands at 0.00%. Joel Greenblatt would question the firm’s cash flow stability or capital allocation decisions.
26.46%
Positive OCF growth while VUZI is negative. John Neff would see this as a clear operational advantage vs. the competitor.
27.78%
Positive FCF growth while VUZI is negative. John Neff would see a strong competitive edge in net cash generation.
377.45%
Positive 10Y revenue/share CAGR while VUZI is negative. John Neff might see a distinct advantage in product or market expansion over the competitor.
66.35%
5Y revenue/share CAGR under 50% of VUZI's 213.13%. Michael Burry would suspect a significant competitive gap or product weakness.
48.59%
3Y revenue/share CAGR at 50-75% of VUZI's 74.76%. Martin Whitman would question if the firm lags behind competitor innovations.
443.54%
10Y OCF/share CAGR above 1.5x VUZI's 83.93%. David Dodd would check if a superior product mix or cost edge drives this outperformance.
102.20%
5Y OCF/share CAGR above 1.5x VUZI's 61.15%. David Dodd would confirm if the firm has better cost structures or brand premium boosting mid-term cash flow.
58.70%
3Y OCF/share CAGR similar to VUZI's 59.25%. Walter Schloss might see both benefiting from a rising tide or parallel expansions.
341.63%
Net income/share CAGR above 1.5x VUZI's 33.56% over 10 years. David Dodd would confirm if brand, IP, or scale secure this persistent advantage.
50.86%
5Y net income/share CAGR at 75-90% of VUZI's 58.94%. Bill Ackman would advocate improvements to match competitor’s profit expansion.
42.83%
3Y net income/share CAGR 50-75% of VUZI's 59.75%. Martin Whitman might see a lagging edge in short-term profitability vs. the competitor.
105.25%
Below 50% of VUZI's 224.72%. Michael Burry would suspect poor capital allocation or persistent net losses eroding long-term equity build-up.
-27.51%
Negative 5Y equity/share growth while VUZI is at 20.45%. Joel Greenblatt sees the competitor building net worth while this firm loses ground.
-41.14%
Negative 3Y equity/share growth while VUZI is at 48.90%. Joel Greenblatt demands an urgent fix in capital structure or profitability vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
56.86%
Dividend/share CAGR of 56.86% while VUZI is zero. Bruce Berkowitz sees a minor advantage in stepping up distributions, even modestly.
29.65%
3Y dividend/share CAGR of 29.65% while VUZI is zero. Bruce Berkowitz sees a minor positive difference that could attract dividend-focused investors.
16.74%
AR growth well above VUZI's 19.41%. Michael Burry fears inflated revenue or higher default risk in the near future.
2.09%
We show growth while VUZI is shrinking stock. John Neff wonders if the competitor is more disciplined or has weaker demand expectations.
2.06%
Asset growth well under 50% of VUZI's 24.77%. Michael Burry sees the competitor as far more aggressive in building resources or capacity.
-8.58%
We have a declining book value while VUZI shows 30.31%. Joel Greenblatt sees a fundamental disadvantage in net worth creation vs. the competitor.
-0.25%
Both reduce debt yoy. Martin Whitman sees a broader sector shift to safer balance sheets or less growth impetus.
4.62%
We increase R&D while VUZI cuts. John Neff sees a short-term profit drag but a potential lead in future innovations.
2.17%
SG&A declining or stable vs. VUZI's 20.41%. David Dodd sees better overhead efficiency if it doesn't hamper revenue.